FOR PATIENTS · SOURCE READING

Early Favorable

Source: Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: February 27, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Stages of Hodgkin Lymphoma / Hodgkin lymphoma may be grouped for treatment as follows:

Early favorable Hodgkin lymphoma is stage I or stage II, without risk factors that increase the chance that the cancer will come back after it is treated.

Source links and citations

stage I
stage II
risk factors

Preserved source evidence · Independent clinical review pending · Not medical advice